Jilin Jianglin Biotechnology

Jilin Jianglin Biotechnology is a specialized biotechnology firm based in Changchun, China, focusing on the frontier of regenerative medicine and cellular therapeutics. The company operates a sophisticated platform for the collection, processing, and cryopreservation of mesenchymal stem cells and immune cells, serving both clinical research and private health management needs. Their research initiatives primarily target chronic metabolic diseases, degenerative joint conditions, and immune system optimization through the use of umbilical cord-derived mesenchymal stem cells (UC-MSCs) and natural killer (NK) cells. Jilin Jianglin Biotechnology maintains a significant presence in the Northeast Asia International Biological Health Industry Incubation Center, where it integrates R&D with advanced manufacturing capabilities. The company aims to bridge the gap between laboratory cell research and practical clinical applications to improve patient outcomes in aging-related and chronic disorders.